Locally advanced lung cancer (stage IIIa, IIIb) in which the primary tumor is proximal (T3) or has invaded adjacent structures (T3) or organs (T4) or in wh... Dirk E. Van Raemdonck and Airton Schneider and Robert J. Ginsberg - 《Annals of Thoracic Surgery》 被引量: 99发表: 1992年...
Survival paradox between stage IIB/C and stage IIIA colon cancer: is it time to revise the American Joint Committee on Cancer TNM system? Introduction A survival paradox between T4N0 (Stage IIB/IIC) and Stage IIIA colon cancer exists, even after adjusting for adequate lymph node (LN) retriev...
Kim TE,Murren JR.Therapy for Stage IIIA, IIIB and IV Non–Small Cell Lung Cancer.Clinical Pulmonary Medicine. 2004Kim TE,Murren JR.Therapy for Stage IIIA, IIIB and IV Non–Small Cell Lung Cancer. Clinical Pulmonary Medicine . 2004Therapy for Stage IIIA, IIIB and IV Non–Small Ce...
Little is known about the relation of multivitamin use to breast cancer outcomes. 2,236 women diagnosed from 1997 to 2000 with early-stage breast cancer (Stage I ≥ 1 cm, II, or IIIA) were enrolled about 2 years post-diagnosis, primarily from the Kaiser Permanente Northern California Cancer...
There were a further 13 cases which were non-concordant at sub-category level (e.g. Stage IIIA vs IIIB). At the stage category level, there was agreement in stage for 393/410 cases (95.8%) with Kendall’s coefficient of concordance of 0.95 indicating a very good level of agreement (...
Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer. Ann Oncol. 1994;5(7):591–5. Article CAS PubMed Google Scholar Blitzblau RC, Arya R, Yoo S, Baker JA, Chang Z, Palta M, et al. A phase 1 trial of ...
During a Targeted Oncology™ Case-Based Roundtable™ event, Garrett B. Sherwood, MD, discussed biopsy and treatment approaches for a patient diagnosed with T2aN2M0, stage IIIA adenocarcinoma.
For patients with stage IIIA and IIIB NSCLC, the median survival time was 26.67 and 24.59 months, respectively. However, considering the difficulty and risk involved in puncture, iodine-125 brachytherapy would not be appropriate, especially for the central lung cancer. Sometimes, limited by the ...
A higher level of HMGB1 was associated with a poorer prognosis or more malignant phenotypes in multiple solid tumors, such as nasopharyngeal, lung, skin, hepatic, gastric, and prostate cancers, with the exception of breast cancer [40–46]. Previous studies have shown that the co-expression of...
Neoadjuvant chemotherapy in potentially resectable stage IIIA-N2 non-small cell lung cancer (NSCLC) has become standard of treatment in the last years. Two... De Marinis,F. - 《Annals of Oncology》 被引量: 35发表: 2005年 Neoadjuvant therapy for breast cancer treatment: an expert panel recomm...